Centre intégré universitaire de santé et de services sociaux de l’Ouest-de-l’Île-de-Montréal
Accueil Plan du site Courrier Portail Québec Passer directement au contenu

Vieillissement et maladie d'Alzheimer

2003

Gauthier S., Rockwood K. (2003). Does vascular MCI progress at a different rate than Amnestic MCI?, Int Psychogeriatr , 15 (suppl. 1) , 257-259.

Hampel H., Teipel S. J., Faltraco F., Pruessner J., Bürger K. (2003). Entwicklung von Positivkriterien zur Diagnose der Alzheimer-Demenz mithilfe bildgebender Verfahren und biologischer Marker – Perspektiven der Alzheimer-Forschung. [Development of positive criteria for the diagnosis of Alzheimer dementia using neuroima . Dans Hampel H., Padberg F., Möller H. J. & Hampel H. (Éds.) , Alzheimer-Demenz. Klinische Verläufe, diagnostische Möglichkeiten, moderne Therapiestrategien (pp. 426–455). Wissenschaftliche Verlagsgesellschaft.

Iaria G., Petrides M., Dagher A., Pike B., Bohbot V. (2003). Cognitive strategies dependent on the hippocampus and caudate nucleus in human navigation: variability and change with practice, J Neurosci , 23 (13 ), 5945-52.

Juaneda C., Dumont Y., Chabot J. G., Fournier A., Quirion R. (2003). Adrenomedullin receptor binding sites in rat brain and peripheral tissues, Eur J Pharmacol , 474 (2-3 ), 165-174.

Law A., Gauthier S., Quirion R. (2003). Alteration of nitric oxide synthase activity in young and aged apolipoprotein E-deficient mice, Neurobiol Aging , 24 (1 ), 187-90.

Leinsinger G., Teipel S. J., Wismuller A., Born C., Meindl T., Flatz W., Schonberg S., Pruessner J., Hampel H., Reiser M. (2003). [Volumetric MRI for evaluation of regional pattern and progressin of neocortical degeneration in Alzheimer's disease], Radiologe , 43 (7 ), 537-42.

Ma W., Chabot J. G., Powell K. J., Jhamandas K., Dickerson I. M., Quirion R. (2003). Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems, Neuroscience , 120 (3 ), 677-94.

Marcotte E. R., Srivastava L., Quirion R. (2003). cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease, Pharmacol Ther , 100 (1 ), 63-74.

Marcusson J., Bullock R., Gauthier S., Kurz A., Schwalen S. (2003). Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease, Alzheimer Dis Assoc Disord , 17 Suppl 3 , S86-91.

Marinelli P. W., Quirion R., Gianoulakis C. (2003). A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration, Psychopharmacology (Berl) , 169 (1 ), 60-67.

Marinelli P. W., Quirion R., Gianoulakis C. (2003). Estradiol valerate and alcohol intake: a comparison between Wistar and Lewis rats and the putative role of endorphins, Behav Brain Res , 139 (1-2 ), 59-67.

O'Brien J. T., Erkinjuntti T., Reisberg B., Roman G., Sawada T., Pantoni L., Bowler J. V., Ballard C., DeCarli C., Gorelick P. B., Rockwood K., Burns A., Gauthier S., DeKosky S. T. (2003). Vascular cognitive impairment, Lancet Neurol , 2 (2 ), 89-98.

O'Donnell J. P., Stemmelin J., Nitta A., Brouillette J., Quirion R. (2003). Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats, Synapse , 50 (3 ), 171-80.

Pheng L. H., Dumont Y., Fournier A., Chabot J. G., Beaudet A., Quirion R. (2003). Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells, Br J Pharmacol , 139 (4 ), 695-704.

Poirier J. (2003). Apolipoprotein E, cholesterol lowering drugs and HMG CoA reductase in sporadic Alzheimer's disease . Dans Iqbal K. & Winblad B. (Éds.) , Alzheimer's disease: Biology, diagnosis and therapeutics (pp. 468-478). J. Wiley and Sons.

Poirier J. (2003). The importance of acetylcholinesterase and butyrylcholinesterase in dementia, Geriatrics and Aging , 6 , 6-10.

Poirier J. (2003). Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease, Trends Mol Med , 9 (3 ), 94-101.

Powell K. J., Quirion R., Jhamandas K. (2003). Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons, Eur J Neurosci , 18 (6 ), 1572-83.

Pruessner J., Hellhammer D. H., Pruessner J., Lupien S. J. (2003). Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening, Psychosom Med , 65 (1 ), 92-9.

Pruessner J., Kirschbaum C., Meinlschmid G., Hellhammer D. H. (2003). Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change, Psychoneuroendocrinology , 28 (7 ), 916-31.

Trier par :
Par année :
  2024
  2023
  2022
  2021
  2020
  2019
  2018
  2017
  2016
  2015
  2014
  2013
  2012
  2011
  2010
  2009
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001

[+] afficher plus

path
send
share
share